- Filed
- May 15, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · May 4, 2023 | 139.71M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2023 | 139.71M sh |
| Shares Diluted restated | Q1 2023 · Mar 31, 2022 | 116.85M sh |
| Capex | Q1 2023 · Mar 31, 2023 | $64.07M |
| Capex | Q1 2023 · Mar 31, 2022 | $7.93M |
| Operating Cash Flow | Q1 2023 · Mar 31, 2023 | −$12.55M |
| Operating Cash Flow | Q1 2023 · Mar 31, 2022 | −$30.14M |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $392.54M |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $443.06M |
| Cash And Equivalents | Q1 2023 · Mar 31, 2022 | $523.21M |
| Stockholders Equity | Q1 2023 · Mar 31, 2023 | $672.48M |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | $717.46M |
| Current Liabilities | Q1 2023 · Mar 31, 2023 | $60.28M |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $62.58M |
| Total Liabilities | Q1 2023 · Mar 31, 2023 | $131.6M |
| Total Liabilities | Q1 2023 · Dec 31, 2022 | $107.57M |
| Current Assets | Q1 2023 · Mar 31, 2023 | $492.12M |
| Current Assets | Q1 2023 · Dec 31, 2022 | $579.46M |
| Total Assets | Q1 2023 · Mar 31, 2023 | $806.57M |
| Total Assets | Q1 2023 · Dec 31, 2022 | $827.7M |
| Eps Diluted | Q1 2023 · Mar 31, 2023 | −$0.09 |
| Eps Diluted | Q1 2023 · Mar 31, 2022 | −$0.30 |
| Eps Basic | Q1 2023 · Mar 31, 2023 | −$0.09 |
| Eps Basic | Q1 2023 · Mar 31, 2022 | −$0.30 |
| Sga Expense | Q1 2023 · Mar 31, 2023 | $30M |
| Sga Expense | Q1 2023 · Mar 31, 2022 | $24.61M |
| Rd Expense | Q1 2023 · Mar 31, 2023 | $4.84M |
| Rd Expense | Q1 2023 · Mar 31, 2022 | $2.86M |
| Net Income | Q1 2023 · Mar 31, 2023 | −$12.73M |
| Net Income | Q1 2023 · Mar 31, 2022 | −$34.91M |
| Operating Income | Q1 2023 · Mar 31, 2023 | −$34.87M |
| Operating Income | Q1 2023 · Mar 31, 2022 | −$27.64M |